B1-induced caspase-independent apoptosis in MCF-7 cells is mediated by down-regulation of Bcl-2 via p53 binding to P2 promoter TATA box

Toxicology and Applied Pharmacology

Volumn 256, Issue 1, 2011, Pages 52-61

  Liang, Xin ^a   Xu, Ke ^a   Xu, Yufang ^a   Liu, Jianwen ^a   Qian, Xuhong ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Bcl 2; DNA intercalator; P53

Indexed keywords

[N (2 (DIMETHYLAMINO)] 2 AMINOTHIAZONAPHTHALIMIDE; CASPASE; DNA; INTERCALATING AGENT; MESSENGER RNA; NAPHTHALIMIDE DERIVATIVE; PROTEIN BCL 2; PROTEIN P2; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN BINDING; TATA BOX;

ANIMALS; APOPTOSIS; CASPASES; DOWN-REGULATION; FEMALE; HELA CELLS; HUMANS; INTERCALATING AGENTS; MICE; MICE, INBRED BALB C; MICE, NUDE; MYELIN P2 PROTEIN; NAPHTHALIMIDES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; TATA BOX; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 80052306413     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.07.010     Document Type: Article

References (28)

1. Andrew T. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 2008, 13:1-9.
2. Bao Q., Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 2007, 14:56-65.
3. Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., Tschopp J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat. Cell Biol. 2000, 2:241-243.
4. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 2003, 39:615-647.
5. Bourgarel-Rey V., El Khyari S., Rimet O., Bordas B., Guigal N., Braguer D., Seree E., Barra Y., Briand C. Opposite effects of antimicrotubule agents on c-myc oncogene expression depending on the cell lines used. Eur. J. Cancer 2000, 36:1043-1049.
6. Bratton S.B., Walker G., Srinivasula S.M., Sun X.M., Butterworth M., Alnemri E.S., Cohen G.M. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 2001, 20:998-1009.
7. 2 region. Gene 2007, 404:110-116.
8. Chen H.M., Boxer L.M. Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol. Cell. Biol. 1995, 15:3840-3847.
9. Decker P., Isenberg D., Muller S. Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J. Biol. Chem. 2000, 275:9043-9046.
10. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 1999, 68:383-424.
11. Fahy B.N., Schlieman M., Virudachalam S., Bold R.J. AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2. Br. J. Cancer 2003, 89:391-397.
12. Heckman C.A., Mehew J.W., Boxer L.M. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene 2002, 21:3898-3908.
13. Ingrassia L., Lefranc F., Kiss R., Mijatovic T. Naphthalimides and azonafides as promising anti-cancer agents. Curr. Med. Chem. 2009, 16:1192-1213.
14. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998, 273:9357-9360.
15. Liang X., Wu A.B., Xu Y.F., Xu K., Liu J.W., Qian X.H. B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activation. Invest. New Drugs 2011, 29:646-658.
16. Mijatovic T., Mahieu T., Bruyère C., De Nève N., Dewelle J., Simon G., Dehoux M.J.M., Aar E., Haibe-Kains B., Bontempi G., Decaestecker C., Quaquebeke E.V., Darro F., Kiss R. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia 2008, 10:573-586.
17. Miyashita T., Harigai M., Hanada M., Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 1994, 54:3131-3135.
18. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Liebermann D.A., Hoffman B., Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9:1799-1805.
19. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299.
20. Qian X.H., Li Z.G., Yang Q. Highly efficient antitumor agents of heterocycles containing sulfur atom: linear and angular thiazonaphthalimides against human lung cancer cell in vitro. Bioorgan. Med. Chem. 2007, 15:6846-6851.
21. Seto M., Jaeger U., Hockett R.D., Graninger W., Bennett S., Goldman P. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 1988, 7:123-131.
22. Singh S., Bhat M.K. Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-kappaB in human HPV-18 E6-positive HEp-2 cells. Biochem. Biophys. Res. Commun. 2004, 318:346-353.
23. Van Q.E., Mahieu T., Dumont P., Dewelle J., Ribaucour F., Simon G., Sauvage S., Gaussin J.F., Tuti J., El Yazidi M., Van Vynckt F., Mijatovic T., Lefranc F., Darro F., Kiss R. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity. J. Med. Chem. 2007, 50:4122-4134.
24. Verma M., Singh S.K., Bhushan S., Sharma V.K., Datt P., Kapahi B.K., Saxena A.K. In vitro cytotoxic potential of Polyalthia longifolia on human cancer cell lines and induction of apoptosis through mitochondrial-dependent pathway in HL-60 cells. Chem. Biol. Interact. 2008, 171:45-56.
25. Wang J., Wu A.B., Xu Y.F., Liu J.W., Qian X.H. M2-A induces apoptosis and G2-M arrest via inhibiting PI3 K/Akt pathway in HL60 cells. Cancer Lett. 2009, 283:193-202.
26. Wilson B.E., Mochon E., Boxer L.M. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell. Biol. 1996, 16:5546-5556.
27. Wu Y., Mehew J.W., Heckman C.A., Arcinas M., Boxer L.M. Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 2001, 20:240-251.
28. Zhu H., Huang M., Yang F., Chen Y., Miao Z.H., Qian X.H., Xu Y.F., Qin Y.X., Luo H.B., Shen X., Geng M.Y., Cai Y.J., Ding J. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II. Mol. Cancer Ther. 2007, 6:484-495.